CA2179019A1 - Nouvelles compositions pour mousses, notamment mousses rectales, et mousses ainsi obtenues - Google Patents

Nouvelles compositions pour mousses, notamment mousses rectales, et mousses ainsi obtenues

Info

Publication number
CA2179019A1
CA2179019A1 CA002179019A CA2179019A CA2179019A1 CA 2179019 A1 CA2179019 A1 CA 2179019A1 CA 002179019 A CA002179019 A CA 002179019A CA 2179019 A CA2179019 A CA 2179019A CA 2179019 A1 CA2179019 A1 CA 2179019A1
Authority
CA
Canada
Prior art keywords
foams
rectal
foaming compositions
resulting
novel foaming
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002179019A
Other languages
English (en)
Other versions
CA2179019C (fr
Inventor
Andre Stamm
Sibel Cepik
Pascal Wehrle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ferring BV
Original Assignee
Andre Stamm
Sibel Cepik
Pascal Wehrle
Scophysa
Laboratoire Pharmaceutique Nordique
Laboratoire Pharmaceutique Noroit
Ferring B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Andre Stamm, Sibel Cepik, Pascal Wehrle, Scophysa, Laboratoire Pharmaceutique Nordique, Laboratoire Pharmaceutique Noroit, Ferring B.V. filed Critical Andre Stamm
Publication of CA2179019A1 publication Critical patent/CA2179019A1/fr
Application granted granted Critical
Publication of CA2179019C publication Critical patent/CA2179019C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Abstract

L'invention a pour objet une composition pour mousse, comprenant, en poids (a) plus de 25 % d'un principe actif sous forme de poudre, (b) de 1 à 20 % d'un tensio-actif; et (c) la balance étant composée d'eau; la poudre dudit principe actif possédant une dimension particulaire inférieure à 20 .mu.m. L'invention a aussi pour objet les mousses obtenues à partir de cette composition et d'un gaz propulseur, notamment pour une application rectale. L'invention a encore pour objet le procédé de préparation de la composition.
CA002179019A 1993-12-14 1994-12-14 Nouvelles compositions pour mousses, notamment mousses rectales, et mousses ainsi obtenues Expired - Fee Related CA2179019C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9314973A FR2713486B1 (fr) 1993-12-14 1993-12-14 Nouvelles compositions pour mousses, notamment mousses rectales, et mousses ainsi obtenues.
FR9314973 1993-12-14
PCT/FR1994/001463 WO1995016433A1 (fr) 1993-12-14 1994-12-14 Nouvelles compositions pour mousses, notamment mousses rectales, et mousses ainsi obtenues

Publications (2)

Publication Number Publication Date
CA2179019A1 true CA2179019A1 (fr) 1995-06-22
CA2179019C CA2179019C (fr) 2002-03-19

Family

ID=9453888

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002179019A Expired - Fee Related CA2179019C (fr) 1993-12-14 1994-12-14 Nouvelles compositions pour mousses, notamment mousses rectales, et mousses ainsi obtenues

Country Status (19)

Country Link
US (1) US5725872A (fr)
EP (1) EP0735860B1 (fr)
JP (1) JP2886688B2 (fr)
KR (1) KR100231767B1 (fr)
AT (1) ATE179596T1 (fr)
AU (1) AU692815B2 (fr)
CA (1) CA2179019C (fr)
CZ (1) CZ291272B6 (fr)
DE (2) DE69418342T2 (fr)
DK (1) DK0735860T3 (fr)
ES (1) ES2093587T3 (fr)
FI (1) FI114139B (fr)
FR (1) FR2713486B1 (fr)
GR (1) GR3030348T3 (fr)
HU (1) HUT74515A (fr)
NO (1) NO312807B1 (fr)
NZ (1) NZ277507A (fr)
PL (1) PL178490B1 (fr)
WO (1) WO1995016433A1 (fr)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4446891A1 (de) * 1994-12-27 1996-07-04 Falk Pharma Gmbh Stabile wäßrige Budesonid-Lösung
CA2287255A1 (fr) 1997-04-22 1998-10-29 Cocensys, Inc. Semicarbazones et thiosemicarbazones carbocycliques et heterocycliques substitues et leur utilisation
GB2335596A (en) * 1998-03-24 1999-09-29 Procter & Gamble Polyalkyleneglycol Copolymers as Lipase Inhibitors
DE19849737A1 (de) * 1998-10-28 2000-05-04 Falk Pharma Gmbh Kombinationsmittel zur Behandlung entzündlicher Darmerkrankungen
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
EP1642885B1 (fr) 2000-08-29 2009-11-11 Biocon Limited Utilisation d'une composition pharmaceutique contenant un dérivé de l'acide para-aminophénylacétique dans le traitement de maladies inflammatoires des voies gastro-intestinales
US8048924B2 (en) * 2001-08-29 2011-11-01 Biocon Limited Methods and compositions employing 4-aminophenylacetic acid compounds
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
KR101108439B1 (ko) 2002-10-25 2012-01-31 포믹스 리미티드 화장료 및 약제용 거품제
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US8119150B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US9211259B2 (en) * 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US7575739B2 (en) * 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
US20080069779A1 (en) * 2003-08-04 2008-03-20 Foamix Ltd. Foamable vehicle and vitamin and flavonoid pharmaceutical compositions thereof
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US20050075407A1 (en) * 2003-08-25 2005-04-07 Foamix Ltd. Foam incorporating eutetic mixture
DK1773767T3 (en) 2004-07-07 2016-03-21 Biocon Ltd Synthesis of azo bound in immune regulatory relations
DE202005011885U1 (de) * 2005-07-28 2006-08-31 Schwan-Stabilo Cosmetics Gmbh & Co. Kg Geschäumte Zubereitung
EP1810666A1 (fr) * 2006-01-19 2007-07-25 Ferring International Center S.A. Composition de mousse
CA2637408C (fr) * 2006-01-19 2013-12-03 Disphar International B.V. Composition moussante
EP2073794A2 (fr) * 2006-11-14 2009-07-01 Foamix Ltd. Compositions d'émulsion pharmaceutiques moussantes, stables et non alcooliques, contenant un émollient onctueux et leurs utilisations
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US20080292560A1 (en) * 2007-01-12 2008-11-27 Dov Tamarkin Silicone in glycol pharmaceutical and cosmetic compositions with accommodating agent
US7645801B2 (en) 2007-01-29 2010-01-12 Alaven Pharmaceutical Llc Reduced irritant enema for treatment of inflammatory bowel disease (IBD)
US20080277084A1 (en) * 2007-05-09 2008-11-13 Buckman Laboratories International, Inc. ASA Sizing Emulsions For Paper and Paperboard
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
WO2010041141A2 (fr) 2008-10-07 2010-04-15 Foamix Ltd. Support expansible à base d’huile et préparations
WO2009072007A2 (fr) 2007-12-07 2009-06-11 Foamix Ltd. Porteurs, formulations, procédés pour formuler des agents actifs instables pour application externe et utilisations associées
CA2712120A1 (fr) 2008-01-14 2009-07-23 Foamix Ltd. Compositions pharmaceutiques pouvant mousser de poloxamere avec des agents actifs et/ou des cellules therapeutiques, et utilisations
WO2009150530A2 (fr) * 2008-06-11 2009-12-17 Ferring International Center Sa Nouvelle composition de mousse
WO2010125470A2 (fr) 2009-04-28 2010-11-04 Foamix Ltd. Véhicule moussant et compositions pharmaceutiques comportant des solvants polaires aprotiques et leurs utilisations
WO2011013008A2 (fr) 2009-07-29 2011-02-03 Foamix Ltd. Compositions hydro-alcooliques moussantes à base d'agents non tensioactifs non polymères, mousses légères, et leurs utilisations
WO2011013009A2 (fr) 2009-07-29 2011-02-03 Foamix Ltd. Compositions hydro-alcooliques moussantes non tensioactives, mousses légères, et leurs utilisations
WO2011064631A1 (fr) 2009-10-02 2011-06-03 Foamix Ltd. Compositions moussantes dépourvues d'agent tensioactif et d'eau et mousses cassables et leurs utilisations
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
US8174881B2 (en) 2009-11-24 2012-05-08 Micron Technology, Inc. Techniques for reducing disturbance in a semiconductor device
MX2020012139A (es) 2016-09-08 2021-01-29 Vyne Pharmaceuticals Inc Composiciones y metodos para tratar rosacea y acne.
US20190351060A1 (en) * 2016-12-16 2019-11-21 Ferring B.V. Rectal Foam Formulations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8909559D0 (en) * 1989-04-26 1989-06-14 Smith Kline French Lab Pharmaceutical compositions
FR2647344B1 (fr) * 1989-05-25 1995-06-02 Physiopharm Sarl Mousse aerosol a usage rectal
WO1992014479A1 (fr) * 1991-02-19 1992-09-03 Tsumura & Co. Composition pour administration par voie rectale de peptides difficiles a absorber

Also Published As

Publication number Publication date
CZ291272B6 (cs) 2003-01-15
GR3030348T3 (en) 1999-09-30
DE69418342D1 (de) 1999-06-10
FI962478A0 (fi) 1996-06-14
HUT74515A (en) 1997-01-28
HU9601628D0 (en) 1996-08-28
ATE179596T1 (de) 1999-05-15
FR2713486B1 (fr) 1996-02-09
FI962478A (fi) 1996-06-14
CA2179019C (fr) 2002-03-19
US5725872A (en) 1998-03-10
WO1995016433A1 (fr) 1995-06-22
EP0735860A1 (fr) 1996-10-09
DE69418342T2 (de) 1999-11-04
ES2093587T3 (es) 1999-07-16
AU692815B2 (en) 1998-06-18
DK0735860T3 (da) 1999-11-01
NO962512D0 (no) 1996-06-13
KR100231767B1 (ko) 1999-11-15
JPH09506605A (ja) 1997-06-30
PL178490B1 (pl) 2000-05-31
PL315032A1 (en) 1996-09-30
NO962512L (no) 1996-08-08
FR2713486A1 (fr) 1995-06-16
ES2093587T1 (es) 1997-01-01
NO312807B1 (no) 2002-07-08
DE735860T1 (de) 1997-06-26
FI114139B (fi) 2004-08-31
NZ277507A (en) 1997-09-22
CZ175696A3 (en) 1997-04-16
AU1275395A (en) 1995-07-03
EP0735860B1 (fr) 1999-05-06
JP2886688B2 (ja) 1999-04-26

Similar Documents

Publication Publication Date Title
AU1275395A (en) Novel foaming compositions, particularly for rectal foams, and resulting foams
AU1191695A (en) Polyol compositions and their use in the preparation of high resilience polyurethane foams
AU569622B2 (en) Crackling aerosol foam
CA2188236A1 (fr) Compositions de 1,1,1,3,3-pentafluoropropane et de 2-methylbutane de type azeotropes
IL97065A0 (en) Aerosol propellant compositions
AU6156486A (en) Foamable compositions and processes for use thereof
EP0936938A4 (fr) Mousses biodegradables pour l'extinction des incendies
AU4685696A (en) Post-foamable foam composition
WO2001049779A3 (fr) Composition pouvant se transformer en mousse en sortant d'un recipient sous pression, destinee a la production de mousses d'isolation
EP0385092A3 (fr) Compositions thermoplastiques moussables
GB1531319A (en) Substantially azeotropic ternary compositions and their use in the preparation of polyurethane foam
GB1498614A (en) Process for the manufacture of foamed gypsum
EP0286601A3 (fr) Composition déodorante en poudre pour chaussures, en particulier pour chaussures de sport
JPS5331582A (en) Aerosol composition
TW374736B (en) Polyol-blowing agent compositions with improved storage stability
ES8205216A1 (es) Procedimiento para la obtencion de 2,4-dioxa-7,10-metano-espiro s',s-undecanos.
MX9704525A (es) Composiciones azeotropicas de dimetoximetano y ciclopentano y su uso en la produccion de espumas.
ES2122837A1 (es) Mezcla gaseosa y procedimiento para prepararla.
JPS5640451A (en) Liquid separating agent
GB2420709A (en) Skin preparation foaming composition
GB1209456A (en) Improvements relating to polyurethane foams
JPS5725314A (en) Production of low-density rigid polyurethane foam
ES8704526A1 (es) Un procedimiento para preparar una espuma de excelente tenacidad a partir de polimeros expandibles estirenicos y etilenicos y un agente de expansion.
JPS5632573A (en) Phonograph record spray
JPS53149266A (en) Foaming polyamide composition

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed